Cytek Biosciences, Inc. CTKB

Latest FY: 2025 Healthcare Medical Devices
Market Price $4.55
Market Cap $587.60M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑0.5% YoY
$201.49M
3-Yr CAGR: 7.1%
Net Income ↓-1,005.3% YoY
-$66.54M
Net Margin: -33.0%
Free Cash Flow ↓-140.1% YoY
-$8.77M
FCF Yield: -1.49%
EPS (Diluted) ↓-940.0% YoY
$-0.52
Basic: $-0.52
Return on Equity Efficiency
-19.5%
ROA: -14.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CTKB)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2020 $92.8M $51.7M $19.4M $0.10 $15.2M $13.6M
FY 2021 $128.0M +37.8% $79.1M $3.0M -84.4% -100.0% 0.00% $4.6M $0.3M -98.0%
FY 2022 $164.0M +28.2% $101.0M $2.5M -17.9% $0.02 0.00% $-12.2M $-22.0M -8,362.8%
FY 2023 $193.0M +17.7% $109.4M $-12.1M -589.0% $-0.09 -550.0% 0.00% $5.3M $0.6M +102.9%
FY 2024 $200.5M +3.9% $111.1M $-6.0M +50.4% $-0.05 +44.4% 0.00% $25.4M $21.9M +3,352.4%
FY 2025 $201.5M +0.5% $104.5M $-66.5M -1,005.3% $-0.52 -940.0% 0.00% $-4.7M $-8.8M -140.1%
$

Valuation

Market Price $4.55
Market Cap $587.60M
Enterprise Value $496.75M
P/E Ratio N/A
P/B Ratio 1.72
FCF Yield -1.49%
Dividend Yield N/A
Shares Outstanding 129,142,599
%

Profitability & Margins

Gross Margin 51.84%
Operating Margin -20.04%
Net Margin -33.02%
Return on Equity (ROE) -19.47%
Return on Assets (ROA) -14.42%
Asset Turnover 0.44x
Revenue 3-Yr CAGR 7.10%
🛡️

Financial Health & Liquidity

Current Ratio 5.04
Cash Ratio 1.17
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $90.85M
Total Debt N/A
Book Value / Share $2.65
💧

Cash Flow Efficiency

Operating Cash Flow -$4.69M
Capital Expenditures (CapEx) $4.08M
Free Cash Flow -$8.77M
OCF / Revenue -2.33%
FCF / Revenue -4.35%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.52
EPS (Basic) $-0.52
Dividends / Share N/A
Book Value / Share $2.65
EPS YoY Growth -940.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $461.54M
Total Liabilities $119.80M
Stockholders' Equity $341.74M
Current Assets $392.00M
Current Liabilities $77.80M